ARCHIVES

Efaproxyn Improved Survival Of Patients With Brain Mets

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Brooks Wins ACS Award. NCI Would Get $4.725 Billion, 12% Increase, In Bush Budget.

February 8, 2002

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

UICC Fellowship Program Announced

January 2, 1981

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010